下腔静脉滤器置入应用于下肢深静脉血栓形成的临床分析  

Benefits of inferior vena cava f＇dter on the deep vein thrombosis and pulmonary embolism

作　　者：索文军[1] 程安源[1] 张海林[1] 张小科[1] 

机构地区：[1]冀中能源峰峰集团有限公司总医院外二科,邯郸056200

出　　处：《中国综合临床》2012年第5期542-544,共3页Clinical Medicine of China

摘　　要：目的探讨下腔静脉滤器（VCF）置入联合抗凝溶栓治疗下肢深静脉血栓形成（DVT）的效果及防治肺动脉栓塞的意义。方法回顾性分析2009年1月至2011年9月我院收治的DVT患者．115例，选择27例适合行VCF置入的患者，在数字减影血管造影术下行VCF置入，术后给予溶栓、抗凝等治疗。结果27例患者下腔静脉内均成功置入VCF，经溶栓、抗凝后患肢肿胀明显消退，术后无肺栓塞及滤器置入相关并发症发生。结论VCF置入联合抗凝溶栓治疗DVT疗效好且安全，VCF置入可有效预防下肢深静脉血栓患者肺栓塞的发生。Objective To investigate the benefit of inferior vena cava filter on the treatment of deep vein thrombosis（DVT） and pulmonary embolism. Methods From January 2009 to September 2011, of the 115 patients with DVT, 27 cases were treated by VCF under DSA, followed by thrombolysis and anticoagulation. Results All the cases were successfully implanted with VCF and limb detumescence was achieved after thrombolysis and anticoagulation treatment without complications. Conclusion The implantation of inferior vena cava filter combined with thrombolysis and anticoagulation is favorable and Safe to treat deep vein thrombosis and pulmonary embolism, and it is also effective to prevent PE in patients with deep venous thrombosis in the low extremity.

关 键 词：深静脉血栓形成 下腔静脉滤器 肺动脉栓塞 抗凝溶栓 

分 类 号：R543.6[医药卫生—心血管疾病]